查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1571027

欧洲的整形外科用生物材料市场:市场规模，趋势及分析(2024年～2030年):MedSuite

Orthopedic Biomaterials Market Size, Share and Trends Analysis | Europe | 2024-2030 | MedSuite | Includes: Bone Graft Substitutes, Orthopedic Growth Factors, and 3 more
出版日期: | 出版商: iData Research Inc. | 英文 464 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年，欧洲骨科生物材料市场规模超过5.54亿欧元。该市场预计将以 2.1% 的复合年增长率成长，到 2030 年将达到近 6.43 亿欧元。

主要人口趋势持续推动欧洲骨科生物材料市场。一个值得注意的因素是脊椎骨关节炎（OA）的发生率不断增加，特别是随着人口老化，促使脊椎融合手术的数量增加。随着第一波婴儿潮世代于 2008 年退休，人口持续老化，对治疗关节炎和退化性椎间盘疾病的治疗需求不断增加。因此，对骨移植替代品的需求不断增长。此外，肥胖率上升进一步加速了退化性疾病的流行，推动了对骨科生物材料和相关手术的需求。预计这些趋势将在预测期内推动市场成长。

凭藉HA关节内替代治疗产品Hyalubrix®和Hyalgan®的强劲表现，Fidia在欧洲骨科生物材料市场保持领先地位。美敦力排名第二主要是因为其 INFUSE(TM) 产品在骨科生长因子市场占据主导地位。 Bioventus 作为 DUROLANE®（主要是单次注射治疗药物）在欧洲的主要经销商，获得了第三大市场占有率。

本报告提供欧洲的整形外科用生物材料市场相关调查，提供市场概要，以及各市场区隔趋势，COVID-19影响分析，推动市场要素及阻碍因素，竞争市场占有率分析，及加入此市场的主要企业简介等资讯。

目录

摘要整理

调查手法

全球消化器官内视镜设备市场上COVID-19的影响

  • 简介
  • 地区简介
  • 各市场区隔分析
    • 最坏案例情势
    • 基本案例情势
    • 最佳案例情势

疾病概要

  • 基本的解剖学
  • 病的治疗和诊断
  • 患者的人口统计

产品评估

  • 简介
  • 产品系列
  • 法规上的问题和回收
  • 临床试验

欧洲的整形外科用生物材料市场概要

  • 简介
  • 汇率
  • 市场概要与趋势分析
  • 促进因素与阻碍因素
  • 竞争市场占有率分析
  • 合併和收购
  • 企业简介
    • Arthrex
    • Biocomposites
    • Bioventus
    • DePuy Synthes
    • Ferring Pharmaceuticals
    • Isto Biologics
    • Medtronic
    • MTF
    • NuVasive
    • Orthofix
    • Sanofi
    • Stryker
    • Terumo
    • Vericel
    • Zimmer Biomet
  • SWOT分析

国家概况

  • 简介
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙
  • 荷比卢三国
  • 斯堪地那维亚
  • 奥地利
  • 瑞士
  • 葡萄牙

手术数量

整形外科用骨移植替代品市场

整形外科用成长因素市场

整形外科用细胞治疗市场

玻尿酸关节内替代疗法市场

整形外科用软骨修復市场

Product Code: iDATA_EUOB24_MS

In 2023, the European market for orthopedic biomaterials was valued at over €554 million. This market is projected to grow at a compound annual growth rate (CAGR) of 2.1%, reaching nearly €643 million by 2030. The full report on the European orthopedic biomaterials market includes bone graft substitutes (allografts, demineralized bone matrices (DBMs), and synthetic bone grafts), orthopedic growth factors, cell therapies (bone marrow aspirate concentrate and platelet-rich plasma), hyaluronic acid (HA) viscosupplementation (single-, two-, three-, and five-injection cycles), and orthopedic cartilage repair (osteochondral allografts, meniscal allografts, autologous chondrocyte implantation, and osteochondral autografts).

MARKET DATA HIGHLIGHTS:

  • Unit sales, average selling prices, market value, and growth trends
  • Forecasts until 2030 and historical data from 2020
  • Market drivers and constraints for each segment
  • Competitive analysis with market shares for each segment
  • Mergers & acquisitions
  • Procedure volumes
  • Company profiles, product portfolios, and SWOT analysis for top competitors

EUROPEAN ORTHOPEDIC BIOMATERIALS MARKET TRENDS

Key demographic trends continue to drive the European orthopedic biomaterials market. A notable factor is the rising incidence of osteoarthritis (OA) in the spine, particularly as the population ages, leading to an increasing number of spinal fusion procedures. With the aging population, driven by the retirement of the first wave of baby boomers starting in 2008, there has been a growing demand for treatments addressing arthritis and degenerative disc disease. This has led to an increased need for bone graft substitutes. Additionally, the prevalence of degenerative diseases is further accelerated by rising obesity rates, driving demand for orthopedic biomaterials and associated procedures. These trends are expected to propel market growth during the forecast period.

EUROPEAN ORTHOPEDIC BIOMATERIALS MARKET SHARE INSIGHTS (2023)

Fidia maintained its leadership position in the European orthopedic biomaterials market, bolstered by the strong performance of its HA viscosupplementation products, Hyalubrix(R) and Hyalgan(R).

Medtronic ranked as the second-largest player, largely due to its dominance in the orthopedic growth factor market with its INFUSE(TM) product.

Bioventus secured the third-largest market share, primarily as the leading distributor of DUROLANE(R), a single-injection treatment, across Europe.

MARKET SEGMENTATION SUMMARY

  • Bone Graft Substitutes Market: Includes allografts, demineralized bone matrices (DBMs), and synthetic bone graft substitutes.
  • Orthopedic Growth Factor Market: Segmented into spine and tibial fracture treatments.
  • Orthopedic Cell Therapy Market: Includes platelet-rich plasma and bone marrow concentration segments.
  • Hyaluronic Acid Viscosupplementation Market: Covers single-injection, two-injection, three-injection, and five-injection products.
  • Orthopedic Cartilage Repair Market: Includes osteochondral allografts, meniscal allografts, autologous chondrocyte implantation (ACI), and osteochondral autografts.

GLOBAL RESEARCH SCOPE SUMMARY

  • Region: Europe (France, U.K., Italy, Spain, Benelux, Scandinavia, Austria, Switzerland, Portugal)
  • Base Year: 2023
  • Forecast: 2024-2030
  • Historical Data: 2020-2022
  • Quantitative Coverage: Market size, market shares, market forecasts, market growth rates, units sold, and average selling prices.
  • Qualitative Coverage: COVID-19 impact, market growth trends, market constraints, competitive analysis, SWOT for top competitors, mergers & acquisitions, company profiles, product portfolios, FDA recalls, disruptive technologies, disease overviews.
  • Data Sources: Primary interviews with industry leaders, government physician data, regulatory data, hospital private data, import/export data, iData Research's internal database.

TABLE OF CONTENT

TABLE of CONTENTS

List of Figures

List of Charts

executive summary

European Orthopedic Biomaterials Market Overview

Competitive Analysis

Emerging Markets and Technologies

Market Trends

Market Developments

Market Segmentation

Procedure Segmentation

Key Report Updates

Version History

research methodology

  • Step 1: Project Initiation & Team Selection
  • Step 2: Prepare Data Systems and Perform Secondary Research
  • Step 3: Preparation for Interviews & Questionnaire Design
  • Step 4: Performing Primary Research
  • Step 5: Research Analysis: Establishing Baseline Estimates
  • Step 6: Market Forecast and Analysis
  • Step 7: Identify Strategic Opportunities
  • Step 8: Final Review and Market Release
  • Step 9: Customer Feedback and Market Monitoring

impact of covid-19 on THE European Orthopedic Biomaterials Market

  • 2.1 Introduction
    • 2.1.1 Treatable Population
  • 2.2 Country Profiles
  • 2.3 Analysis By Market Segment
    • 2.3.1 Worst Case Scenario
    • 2.3.2 Base Case Scenario
    • 2.3.3 Best Case Scenario

Product Assessment

  • 3.1 Introduction
  • 3.2 Product Portfolios
    • 3.2.1 Bone Graft Substitutes
    • 3.2.2 Growth Factors
      • 3.2.2.1.1 NELL-1 Bone Biologics
      • 3.2.2.1.2 INFUSE(R) by Medtronic
      • 3.2.2.1.3 OsteoAMP(R) by Bioventus Surgical
      • 3.2.2.1.4 OP-1(TM) by Stryker/Olympus Biotech (Delisted)
      • 3.2.2.1.5 The Osteogrow Study
      • 3.2.2.1.6 AUGMENT(R) Bone Graft
      • 3.2.2.1.7 Amplex(R) Osteobiologic Bone Graft Substitute
      • 3.2.2.1.8 i-Factor(TM) Peptide Bone Matrix
    • 3.2.3 Cell Therapy
      • 3.2.3.1 Platelet-Rich Plasma
      • 3.2.3.2 Bone Marrow Aspirate Concentrate
    • 3.2.4 Hyaluronic Acid Viscosupplementation (HAV)
    • 3.2.5 Cartilage Repair
  • 3.3 Regulatory Issues and Recalls
    • 3.3.1 Bone Graft Substitute Market FDA Recalls
    • 3.3.2 Growth Factor Market FDA Recalls
  • 3.4 Clinical Trials
    • 3.4.1 Bone Graft Substitute Market Clinical Trials
    • 3.4.2 Growth Factor Market Clinical Trials
    • 3.4.3 Cell Therapy Market Clinical Trials
    • 3.4.4 Hyaluronic Acid Viscosupplementation Market
    • 3.4.5 Cartilage Repair Market Clinical Trials

European Orthopedic Biomaterials Market Overview

  • 4.1 Introduction
  • 4.2 Currency Exchange Rate
  • 4.3 Market Overview & Trend Analysis
  • 4.4 Drivers and Limiters
    • 4.4.1 Market Drivers
    • 4.4.2 Market Limiters
  • 4.5 Competitive Market Share Analysis
  • 4.6 Mergers and Acquisitions
  • 4.7 Company Profiles
    • 4.7.1 Arthrex
    • 4.7.2 Biocomposites
    • 4.7.3 Bioventus
    • 4.7.4 DePuy Synthes
    • 4.7.5 Ferring Pharmaceuticals
    • 4.7.6 Isto Biologics
    • 4.7.7 Medtronic
    • 4.7.8 MTF
    • 4.7.9 NuVasive
    • 4.7.10 Orthofix
    • 4.7.11 Sanofi
    • 4.7.12 Stryker
    • 4.7.13 Terumo
    • 4.7.14 Vericel
    • 4.7.15 Zimmer Biomet
  • 4.8 SWOT Analysis
    • 4.8.1 Arthrex
    • 4.8.2 Biocomposites
    • 4.8.3 Bioventus
    • 4.8.4 DePuy Synthes
    • 4.8.5 Ferring Pharmaceuticals
    • 4.8.6 Isto Biologics
    • 4.8.7 Medtronic
    • 4.8.8 MTF
    • 4.8.9 NuVasive
    • 4.8.10 Orthofix
    • 4.8.11 Sanofi
    • 4.8.12 Stryker
    • 4.8.13 Terumo
    • 4.8.14 Vericel
    • 4.8.15 Zimmer Biomet

Country Profiles

  • 5.1 Introduction
    • 5.1.1 GDP Per Capita
    • 5.1.2 Price Index
  • 5.2 Germany
  • 5.3 France
  • 5.4 United Kingdom
  • 5.5 Italy
  • 5.6 Spain
  • 5.7 Benelux
  • 5.8 Scandinavia
  • 5.9 Austria
  • 5.10 Switzerland
  • 5.11 Portugal

Procedure Numbers

  • 6.1 Introduction
  • 6.2 Procedures
    • 6.2.1 Orthopedic Bone Grafting Procedures
      • 6.2.1.1 Orthopedic Bone Grafting Procedures by Material
      • 6.2.1.2 Orthopedic Bone Grafting Procedures by Indication
      • 6.2.1.2.1 Average Units Used per Procedure by Indication
      • 6.2.1.3 Allograft Procedures by Indication
      • 6.2.1.4 DBM Procedures by Indication
      • 6.2.1.5 Synthetic Procedures by Indication
      • 6.2.1.6 Orthopedic Bone Grafting Procedures by Care Setting
    • 6.2.2 Orthopedic Growth Factor Procedures
      • 6.2.2.1 Orthopedic Growth Factor Procedures by Indication
      • 6.2.2.2 Orthopedic Growth Factor Procedures by Care Setting
    • 6.2.3 Orthopedic Cell Therapy Procedures
      • 6.2.3.1 Orthopedic Cell Therapy Procedures by Material Type
      • 6.2.3.2 Platelet-Rich Plasma Procedures
      • 6.2.3.3 Bone Marrow Aspirate Concentrate Procedures
      • 6.2.3.1 Orthopedic Cell Therapy Procedures by Care Setting
    • 6.2.4 Hyaluronic Acid Viscosupplementation Procedures
      • 6.2.4.1 Hyaluronic Acid Viscosupplementation Procedures by Injection Cycle
      • 6.2.4.1 Hyaluronic Acid Viscosupplementation Procedures by Care Setting
    • 6.2.5 Orthopedic Cartilage Repair Procedures
      • 6.2.5.1 Orthopedic Cartilage Repair Procedures by Type
      • 6.2.5.2 Orthopedic Cartilage Repair Procedures by Care Setting

orthopedic Bone Graft Substitute Market

  • 7.1 Introduction
  • 7.2 Market Overview
  • 7.3 Market Analysis and Forecast
    • 7.3.1 Total Bone Graft Substitute Market
    • 7.3.2 Allograft Bone Graft Substitute Market
    • 7.3.3 Demineralized Bone Matrix Bone Graft Substitute Market
    • 7.3.4 Synthetic Bone Graft Substitute Market
  • 7.4 Unit Analysis
    • 7.4.1 Total Bone Graft Substitute Unit Analysis
    • 7.4.2 Allograft Bone Graft Substitute Unit Analysis
      • 7.4.2.1 Allograft Bone Graft Substitute Units Sold by Indication
      • 7.4.2.1.1 Spine Allograft Bone Graft Substitute Units Sold by Anatomy
      • 7.4.2.1.2 Trauma Allograft Bone Graft Substitute Units Sold by Anatomy
      • 7.4.2.1.3 Large Joint Reconstruction Allograft Bone Graft Substitute Units Sold by Anatomy
      • 7.4.2.1.4 Foot Reconstruction Allograft Bone Graft Substitute Units Sold
      • 7.4.2.1.5 Craniomaxillofacial Allograft Bone Graft Substitute Units Sold
      • 7.4.2.1.6 Oncology Allograft Bone Graft Substitute Units Sold
    • 7.4.3 Demineralized Bone Matrix Allograft Unit Analysis
      • 7.4.3.1 Demineralized Bone Matrix Allograft Units Sold by Indication
      • 7.4.3.1.1 Spine Demineralized Bone Matrix Allograft Units Sold by Anatomy
      • 7.4.3.1.2 Trauma Demineralized Bone Matrix Allograft Units Sold by Anatomy
      • 7.4.3.1.3 Craniomaxillofacial Demineralized Bone Matrix Allograft Units Sold
    • 7.4.4 Synthetic Bone Graft Substitute Unit Analysis
      • 7.4.4.1 Synthetic Bone Graft Substitute Units Sold by Indication
      • 7.4.4.1.1 Spine Synthetic Bone Graft Substitute Units Sold by Anatomy
      • 7.4.4.1.2 Trauma Synthetic Bone Graft Substitute Units Sold by Anatomy
      • 7.4.4.1.3 Large Joint Reconstruction Synthetic Bone Graft Substitute Units Sold by Anatomy
      • 7.4.4.1.4 Foot Reconstruction Synthetic Bone Graft Substitute Units Sold
      • 7.4.4.1.5 Craniomaxillofacial Synthetic Bone Graft Substitute Units Sold
      • 7.4.4.1.6 Oncology Synthetic Bone Graft Substitute Units Sold
      • 7.4.4.2 Synthetic Bone Graft Substitute Market by Generation Type
      • 7.4.4.2.1 Generation 1 Synthetic Bone Graft Substitute Market
      • 7.4.4.2.2 Generation 2 Synthetic Bone Graft Substitute Market
  • 7.5 Drivers and Limiters
    • 7.5.1 Market Drivers
    • 7.5.2 Market Limiters
  • 7.6 Competitive Market Share Analysis

ORthopedic Growth Factor Market

  • 8.1 Introduction
    • 8.1.1 BMP-2 (Medtronic)
  • 8.2 Market Overview
  • 8.3 Market Analysis and Forecast
    • 8.3.1 Orthopedic Growth Factor Market
    • 8.3.2 Spine Fracture Orthopedic Growth Factor Market
    • 8.3.3 Tibial Fracture Orthopedic Growth Factor Market
  • 8.4 Unit Analysis
    • 8.4.1 Spine Orthopedic Growth Factor Unit Analysis
    • 8.4.2 Tibial Fracture Orthopedic Growth Factor Unit Analysis
  • 8.5 Drivers and Limiters
    • 8.5.1 Market Drivers
    • 8.5.2 Market Limiters
  • 8.6 Competitive Market Share Analysis

Orthopedic Cell Therapy Market

  • 9.1 Introduction
  • 9.2 Market Overview
  • 9.3 Market Analysis and Forecast
    • 9.3.1 Platelet-Rich Plasma Market
    • 9.3.2 Bone Marrow Aspirate Concentrate Market
  • 9.4 Unit Analysis
    • 9.4.1 Platelet-Rich Plasma Units Sold by Indication
      • 9.4.1.1 Soft-Tissue Platelet-Rich Plasma Units Sold
      • 9.4.1.2 Spine Platelet-Rich Plasma Units Sold
      • 9.4.1.3 Cardiac Platelet-Rich Plasma Units Sold
      • 9.4.1.4 Orthopedic Platelet-Rich Plasma Units Sold
      • 9.4.1.5 Plastics Platelet-Rich Plasma Units Sold
    • 9.4.2 Bone Marrow Aspirate Concentrate Units Sold by Indication
      • 9.4.2.1 Spine Bone Marrow Aspirate Concentrate Units Sold
      • 9.4.2.2 Soft-Tissue Bone Marrow Aspirate Concentrate Units Sold
      • 9.4.2.3 Trauma Bone Marrow Aspirate Concentrate Units Sold
      • 9.4.2.4 Joint Reconstruction Bone Marrow Aspirate Concentrate Units Sold
  • 9.5 Drivers and Limiters
    • 9.5.1 Market Drivers
    • 9.5.2 Market Limiters
  • 9.6 Competitive Market Share Analysis

Hyaluronic Acid Viscosupplementation Market

  • 10.1 Introduction
    • 10.1.1 Benefits of Viscosupplementation
    • 10.1.2 Synovial Fluid
    • 10.1.3 Product Types
  • 10.2 Market Overview
  • 10.3 Market Analysis and Forecast
    • 10.3.1 Total Hyaluronic Acid Viscosupplementation Market
    • 10.3.2 Single-Injection Hyaluronic Acid Viscosupplementation Market
    • 10.3.3 Two-Injection Hyaluronic Acid Viscosupplementation Market
    • 10.3.4 Three-Injection Hyaluronic Acid Viscosupplementation Market
    • 10.3.5 Five-Injection Hyaluronic Acid Viscosupplementation Market
  • 10.4 Drivers and Limiters
    • 10.4.1 Market Drivers
    • 10.4.2 Market Limiters
  • 10.5 Competitive Market Share Analysis

Orthopedic Cartilage Repair Market

  • 11.1 Introduction
    • 11.1.1 Anatomy
    • 11.1.2 Methods for Cartilage Repair
      • 11.1.2.1 Osteochondral Allograft Transfer
      • 11.1.2.2 Autologous Chondrocyte Implantation (ACI)
      • 11.1.2.3 Meniscal Allograft Transplantation
      • 11.1.2.4 Osteochondral Autograft
  • 11.2 Market Overview
  • 11.3 Market Analysis and Forecast
    • 11.3.1 Osteochondral Allograft Market
    • 11.3.2 Meniscal Allograft Market
    • 11.3.3 Autologous Chondrocyte Implantation Market
    • 11.3.4 Osteochondral Autograft Market
  • 11.4 Drivers and Limiters
    • 11.4.1 Market Drivers
    • 11.4.2 Market Limiters
  • 11.5 Competitive Market Share Analysis

Abbreviations

LIST OF CHARTS

  • Chart 1-1: Orthopedic Biomaterials Market by Segment, Europe, 2023
  • Chart 1-2: Orthopedic Biomaterials Market Overview, Europe, 2023 & 2030
  • Chart 2-1: Multi-Scenario Orthopedic Biomaterials Market Forecast, Europe, 2020 - 2030 (€M)
  • Chart 4-1: Orthopedic Biomaterials Market by Segment, Europe, 2020 - 2030
  • Chart 4-2: Leading Competitors, Orthopedic Biomaterials Market, Europe, 2023
  • Chart 5-1: Country Profile, Germany, 2023
  • Chart 5-2: Country Profile, France, 2023
  • Chart 5-3: Country Profile, United Kingdom, 2023
  • Chart 5-4: Country Profile, Italy, 2023
  • Chart 5-5: Country Profile, Spain, 2023
  • Chart 5-6: Country Profile, Benelux, 2023
  • Chart 5-7: Country Profile, Scandinavia, 2023
  • Chart 5-8: Country Profile, Austria, 2023
  • Chart 5-9: Country Profile, Switzerland, 2023
  • Chart 5-10: Country Profile, Portugal, 2023
  • Chart 7-1: Bone Graft Substitute Market by Segment, Europe, 2020 - 2030
  • Chart 7-2: Leading Competitors, Orthopedic Bone Graft Substitute Market, Europe, 2023
  • Chart 9-1: Orthopedic Cell Therapy Market by Segment, Europe, 2020 - 2030
  • Chart 9-2: Leading Competitors, Orthopedic Cell Therapy Market, Europe, 2023
  • Chart 10-1: Hyaluronic Acid Viscosupplementation Market by Segment, Europe, 2020 - 2030
  • Chart 10-2: Leading Competitors, Hyaluronic Acid Viscosupplementation Market, Europe, 2023
  • Chart 11-1: Orthopedic Cartilage Repair Market by Segment, Europe, 2020 - 2030
  • Chart 11-2: Leading Competitors, Orthopedic Cartilage Repair Market, Europe, 2023

LIST OF FIGURES

  • Figure 1-1: Orthopedic Biomaterials Market Share Ranking by Segment, Europe, 2023
  • Figure 1-2: Companies Researched in This Report
  • Figure 1-3: Factors Impacting the Orthopedic Biomaterials Market by Segment, Europe (1 of 2)
  • Figure 1-4: Factors Impacting the Orthopedic Biomaterials Market by Segment, Europe (2 of 2)
  • Figure 1-5: Recent Events in the Orthopedic Biomaterials Market, Europe, 2021 - 2024 (1 of 7)
  • Figure 1-6: Recent Events in the Orthopedic Biomaterials Market, Europe, 2021 - 2024 (2 of 7)
  • Figure 1-7: Recent Events in the Orthopedic Biomaterials Market, Europe, 2021 - 2024 (3 of 7)
  • Figure 1-8: Recent Events in the Orthopedic Biomaterials Market, Europe, 2021 - 2024 (4 of 7)
  • Figure 1-9: Recent Events in the Orthopedic Biomaterials Market, Europe, 2021 - 2024 (5 of 7)
  • Figure 1-10: Recent Events in the Orthopedic Biomaterials Market, Europe, 2021 - 2024 (6 of 7)
  • Figure 1-11: Recent Events in the Orthopedic Biomaterials Market, Europe, 2021 - 2024 (7 of 7)
  • Figure 1-12: Orthopedic Biomaterials Market Segmentation, Europe (1 of 2)
  • Figure 1-13: Orthopedic Biomaterials Market Segmentation, Europe (2 of 2)
  • Figure 1-14: Orthopedic Biomaterials Procedure Segmentation, Europe (1 of 3)
  • Figure 1-15: Orthopedic Biomaterials Procedure Segmentation, Europe (2 of 3)
  • Figure 1-16: Orthopedic Biomaterials Procedure Segmentation, Europe (3 of 3)
  • Figure 1-17: Key Report Updates (1 of 2)
  • Figure 1-18: Version History
  • Figure 2-1: Orthopedic Biomaterials Market by Segment, Worst Case Scenario, Europe, 2020 - 2030 (€M)
  • Figure 2-2: Orthopedic Biomaterials Market by Segment, Base Case Scenario, Europe, 2020 - 2030 (€M)
  • Figure 2-3: Orthopedic Biomaterials Market by Segment, Best Case Scenario, Europe, 2020 - 2030 (€M)
  • Figure 3-1: Bone Graft Substitutes Products by Company (1 of 4)
  • Figure 3-2: Bone Graft Substitutes Products by Company (2 of 4)
  • Figure 3-3: Bone Graft Substitutes Products by Company (3 of 4)
  • Figure 3-4: Bone Graft Substitutes Products by Company (4 of 4)
  • Figure 3-5: Growth Factor Products by Company
  • Figure 3-6: Cell Therapy Products by Company
  • Figure 3-7: Hyaluronic Acid Viscosupplementation by Products by Company
  • Figure 3-8: Cartilage Repair Products by Company
  • Figure 3-9: Class 2 Device Recall GRAFTON DBM (Gel, Flex, Putty, Matrix, Crunch)
  • Figure 3-10: Class 2 Device Recall GRAFTON PLUS DBM Paste
  • Figure 3-11: Class 2 Device Recall Magnifuse Bone Graft
  • Figure 3-12: Class 2 Device Recall Grafton DBF Inject
  • Figure 3-13: Class 2 Device Recall OsteoSelect Demineralized Bone Matrix (DBM) Putty
  • Figure 3-14: Class 2 Device Recall PROSTIM 10cc INJECTABLE
  • Figure 3-15: Class 2 Device Recall Opteform Allograft Disc
  • Figure 3-16: Class 2 Device Recall Bioactive Bone Graft Putty
  • Figure 3-17: Class 3 Device Recall iFACTOR Peptide Enhanced Bone Graft Putty
  • Figure 3-18: ACDF Using Structural Allograft vs. Tritanium C
  • Figure 3-19: Clinical Study of Bone Graft Substitutes in Orthopaedic and Spinal Applications
  • Figure 3-20: OSTEOAMP Lumbar Fusion Intra-Patient Controlled Study
  • Figure 3-21: Rate of Bony Fusion Using NanoBone(R) Synthetic Bone Graft Versus Local Autologous Bone Graft. (BONE)
  • Figure 3-22: Demineralized Bone Matrix Rotator Cuff Study
  • Figure 3-23: Clinical Outcomes Associated with the Use of ViviGen(R) for the Treatment of Lumbar Degenerative Disc Disease
  • Figure 3-24: The Effect of Bone-void Filler on Anterior Knee Pain Following ACL Reconstruction
  • Figure 3-25: Long-term Safety and Effectiveness of AUGMENT(R) Injectable Bone Graft Compared to Autologous Bone Graft
  • Figure 3-26: Transforaminal Lumbar Interbody Fusion (TLIF)
  • Figure 3-27: A Post Market Surveillance on INFUSE Bone Graft
  • Figure 3-28: Long-term Safety and Effectiveness of AUGMENT(R) Injectable Bone Graft Compared to Autologous Bone Graft
  • Figure 3-29: Evaluation of the Effectiveness of AMPLEX(R) Compared to Autogenous Bone Grafts
  • Figure 3-30: Effect of PRP, PPP, & BMAC on Functional Outcomes Following Hip Arthroscopy for Acetabular Labral Pathologies
  • Figure 3-31: Bone Marrow Aspirate Concentrate (BMAC) vs Corticosteroid Injection
  • Figure 3-32: BMAC & Allograft vs BMP-2
  • Figure 3-33: Bone Marrow Aspirate Concentrate (BMAC)Treatment for Knee Osteoarthritis (BMAC)
  • Figure 3-34: Platelet Rich Plasma in Knee Osteoarthritis
  • Figure 3-35: Platelet-Rich Plasma (PRP) for Treatment of Symptomatic Lumbar Facet Syndrome of the Spine
  • Figure 3-36: A Prospective Study of Clinical Outcomes Following a Single Intradiscal Injection of Bone Marrow Aspirate Concentrate (BMAC) for Single Level Discogenic Low Back Pain
  • Figure 3-37: ArtiAid(R) for Knee Osteoarthritis: A Post-market Study
  • Figure 3-38: The Effectiveness of Different Doses of Hyaluronic Acid Injections in Knee Osteoarthritis
  • Figure 3-39: Euflexxa for the Treatment of Osteoarthritis
  • Figure 3-40: MONOVISC for Ankle Joint Pain Relief
  • Figure 3-41: MONOVISC for Shoulder Joint Pain Relief
  • Figure 3-42: MONOVISC for Hip Joint Pain Relief
  • Figure 3-43: Comparison of Hyaluronic Acid and Platelet-Rich Plasma Injections
  • Figure 3-44: Prospective Evaluation of ProChondrix CR for Repair of Articular Cartilage Defects on Femoral Condyle and Patella
  • Figure 3-45: Osteochondral Allograft in the Surgical Treatment of Basal Joint Arthritis
  • Figure 3-46: Phase 2 Clinical Trial of CartiLife(R) in the United States
  • Figure 3-47: A Study to Evaluate the Efficacy of BioCartilage(R) Micronized Cartilage Matrix in Microfracture Treatment of Osteochondral Defects
  • Figure 4-1: Currency Exchange Rate, 2023
  • Figure 4-2: Orthopedic Biomaterials Market by Segment, Europe, 2020 - 2030 (€M)
  • Figure 4-3: Orthopedic Biomaterials Market by Segment, Europe, 2020 - 2030 (US$M)
  • Figure 4-4: Leading Competitors, Orthopedic Biomaterials Market, Europe, 2023 (1 of 2)
  • Figure 4-5: Leading Competitors, Orthopedic Biomaterials Market, Europe, 2023 (2 of 2)
  • Figure 4-6: SWOT Analysis, Arthrex
  • Figure 4-7: SWOT Analysis, Biocomposites
  • Figure 4-8: SWOT Analysis, Bioventus
  • Figure 4-9: SWOT Analysis, DePuy Synthes
  • Figure 4-10: SWOT Analysis, Ferring Pharmaceuticals
  • Figure 4-11: SWOT Analysis, Isto Biologics
  • Figure 4-12: SWOT Analysis, Medtronic
  • Figure 4-13: SWOT Analysis, MTF
  • Figure 4-14: SWOT Analysis, NuVasive
  • Figure 4-15: SWOT Analysis, Orthofix
  • Figure 4-16: SWOT Analysis, Sanofi
  • Figure 4-17: SWOT Analysis, Stryker
  • Figure 4-18: SWOT Analysis, Terumo
  • Figure 4-19: SWOT Analysis, Vericel
  • Figure 4-20: SWOT Analysis, Zimmer Biomet
  • Figure 6-1: Orthopedic Biomaterials Procedures by Segment, Europe, 2020 - 2030
  • Figure 6-2: Orthopedic Biomaterials Procedures by Segment, Europe, 2020 - 2030
  • Figure 6-3: Orthopedic Bone Grafting Procedures by Country, Europe, 2020 - 2030
  • Figure 6-4: Orthopedic Bone Grafting Procedures by Material, Europe, 2020 - 2030
  • Figure 6-5: Orthopedic Bone Grafting Procedures by Indication, Europe, 2020 - 2030 (1 of 2)
  • Figure 6-6: Orthopedic Bone Grafting Procedures by Indication, Europe, 2020 - 2030 (2 of 2)
  • Figure 6-7: Cervical Spine Procedures by Country, Europe, 2020 - 2030
  • Figure 6-8: Thoracolumbar Spine Procedures by Country, Europe, 2020 - 2030
  • Figure 6-9: Non-Union Trauma Procedures by Country, Europe, 2020 - 2030
  • Figure 6-10: Fresh Fracture Trauma Procedures by Country, Europe, 2020 - 2030
  • Figure 6-11: Hip Procedures by Country, Europe, 2020 - 2030
  • Figure 6-12: Knee Procedures by Country, Europe, 2020 - 2030
  • Figure 6-13: Foot Procedures by Country, Europe, 2020 - 2030
  • Figure 6-14: Craniomaxillofacial Procedures by Country, Europe, 2020 - 2030
  • Figure 6-15: Oncology Procedures by Country, Europe, 2020 - 2030
  • Figure 6-16: Average Units Used per Procedure by Indication, Europe, 2020 - 2030
  • Figure 6-17: Allograft Procedures by Country, Europe, 2020 - 2030
  • Figure 6-18: Allograft Procedures by Indication, Europe, 2020 - 2030 (1 of 2)
  • Figure 6-19: Allograft Procedures by Indication, Europe, 2020 - 2030 (2 of 2)
  • Figure 6-20: Allograft Cervical Spine Procedures by Country, Europe, 2020 - 2030
  • Figure 6-21: Allograft Thoracolumbar Spine Procedures by Country, Europe, 2020 - 2030
  • Figure 6-22: Allograft Non-Union Trauma Procedures by Country, Europe, 2020 - 2030
  • Figure 6-23: Allograft Fresh Fracture Trauma Procedures by Country, Europe, 2020 - 2030
  • Figure 6-24: Allograft Hip Large Joint Reconstruction Procedures by Country, Europe, 2020 - 2030
  • Figure 6-25: Allograft Knee Large Joint Reconstruction Procedures by Country, Europe, 2020 - 2030
  • Figure 6-26: Allograft Foot Reconstruction Procedures by Country, Europe, 2020 - 2030
  • Figure 6-27: Allograft Craniomaxillofacial Procedures by Country, Europe, 2020 - 2030
  • Figure 6-28: Allograft Oncology Procedures by Country, Europe, 2020 - 2030
  • Figure 6-29: DBM Procedures by Country, Europe, 2020 - 2030
  • Figure 6-30: DBM Procedures by Indication, Europe, 2020 - 2030
  • Figure 6-31: DBM Cervical Spine Procedures by Country, Europe, 2020 - 2030
  • Figure 6-32: DBM Thoracolumbar Spine Procedures by Country, Europe, 2020 - 2030
  • Figure 6-33: DBM Non-Union Trauma Procedures by Country, Europe, 2020 - 2030
  • Figure 6-34: DBM Fresh Fracture Trauma Procedures by Country, Europe, 2020 - 2030
  • Figure 6-35: DBM Craniomaxillofacial Procedures by Country, Europe, 2020 - 2030
  • Figure 6-36: Synthetic Procedures by Country, Europe, 2020 - 2030
  • Figure 6-37: Synthetic Procedures by Indication, Europe, 2020 - 2030 (1 of 2)
  • Figure 6-38: Synthetic Procedures by Indication, Europe, 2020 - 2030 (2 of 2)
  • Figure 6-39: Synthetic Cervical Spine Procedures by Country, Europe, 2020 - 2030
  • Figure 6-40: Synthetic Thoracolumbar Spine Procedures by Country, Europe, 2020 - 2030
  • Figure 6-41: Synthetic Non-Union Trauma Procedures by Country, Europe, 2020 - 2030
  • Figure 6-42: Synthetic Fresh Fracture Trauma Procedures by Country, Europe, 2020 - 2030
  • Figure 6-43: Synthetic Hip Large Joint Reconstruction Procedures by Country, Europe, 2020 - 2030
  • Figure 6-44: Synthetic Knee Large Joint Reconstruction Procedures by Country, Europe, 2020 - 2030
  • Figure 6-45: Synthetic Foot Reconstruction Procedures by Country, Europe, 2020 - 2030
  • Figure 6-46: Synthetic Craniomaxillofacial Procedures by Country, Europe, 2020 - 2030
  • Figure 6-47: Synthetic Oncology Procedures by Country, Europe, 2020 - 2030
  • Figure 6-48: Orthopedic Bone Grafting Procedures by Care Setting, Europe, 2020 - 2030
  • Figure 6-49: Orthopedic Growth Factor Procedures by Country, Europe, 2020 - 2030
  • Figure 6-50: Orthopedic Growth Factor Procedures by Indication, Europe, 2020 - 2030
  • Figure 6-51: Spine Growth Factor Procedures by Country, Europe, 2020 - 2030
  • Figure 6-52: Tibial Growth Factor Procedures by Country, Europe, 2020 - 2030
  • Figure 6-53: Orthopedic Growth Factor Procedures by Care Setting, Europe, 2020 - 2030
  • Figure 6-54: Orthopedic Cell Therapy Procedures by Country, Europe, 2020 - 2030
  • Figure 6-55: Orthopedic Cell Therapy Procedures by Material Type, Europe, 2020 - 2030
  • Figure 6-56: Platelet-Rich Plasma Procedures by Country, Europe, 2020 - 2030
  • Figure 6-57: Bone Marrow Aspirate Concentrate Procedures by Indication, Europe, 2020 - 2030
  • Figure 6-58: Orthopedic Cell Therapy Procedures by Care Setting, Europe, 2020 - 2030
  • Figure 6-59: Hyaluronic Acid Viscosupplementation Total Injections by Country, Europe, 2020 - 2030
  • Figure 6-60: Hyaluronic Acid Viscosupplementation Procedures by Injection Cycle, Europe, 2020 - 2030 (1 of 2)
  • Figure 6-61: Hyaluronic Acid Viscosupplementation Procedures by Injection Cycle, Europe, 2020 - 2030 (2 of 2)
  • Figure 6-62: Single-Injection Cycles by Country, Europe, 2020 - 2030
  • Figure 6-63: Two-Injection Cycles by Country, Europe, 2020 - 2030
  • Figure 6-64: Three-Injection Cycles by Country, Europe, 2020 - 2030
  • Figure 6-65: Five-Injection Cycles by Country, Europe, 2020 - 2030
  • Figure 6-66: Hyaluronic Acid Viscosupplementation Procedures by Care Setting, Europe, 2020 - 2030
  • Figure 6-67: Orthopedic Cartilage Repair Procedures by Type, Europe, 2020 - 2030
  • Figure 6-68: Orthopedic Cartilage Repair Procedures by Care Setting, Europe, 2020 - 2030
  • Figure 7-1: Bone Graft Substitute Market by Segment, Europe, 2020 - 2030 (€M)
  • Figure 7-2: Bone Graft Substitute Market by Segment, Europe, 2020 - 2030 (US$M)
  • Figure 7-3: Total Bone Graft Substitute Market, Europe, 2020 - 2030
  • Figure 7-4: Units Sold by Country, Total Bone Graft Substitute Market, Europe, 2020 - 2030
  • Figure 7-5: Average Selling Price by Country, Total Bone Graft Substitute Market, Europe, 2020 - 2030 (€)
  • Figure 7-6: Average Selling Price by Country, Total Bone Graft Substitute Market, Europe, 2020 - 2030 (US$)
  • Figure 7-7: Market Value by Country, Total Bone Graft Substitute Market, Europe, 2020 - 2030 (€M)
  • Figure 7-8: Market Value by Country, Total Bone Graft Substitute Market, Europe, 2020 - 2030 (US$M)
  • Figure 7-9: Allograft Market, Europe, 2020 - 2030
  • Figure 7-10: Units Sold by Country, Allograft Market, Europe, 2020 - 2030
  • Figure 7-11: Average Selling Price by Country, Allograft Market, Europe, 2020 - 2030 (€)
  • Figure 7-12: Average Selling Price by Country, Allograft Market, Europe, 2020 - 2030 (US$)
  • Figure 7-13: Market Value by Country, Allograft Market, Europe, 2020 - 2030 (€M)
  • Figure 7-14: Market Value by Country, Allograft Market, Europe, 2020 - 2030 (US$M)
  • Figure 7-15: Demineralized Bone Matrix Market, Europe, 2020 - 2030
  • Figure 7-16: Units Sold by Country, Demineralized Bone Matrix Market, Europe, 2020 - 2030
  • Figure 7-17: Average Selling Price by Country, Demineralized Bone Matrix Market, Europe, 2020 - 2030 (€)
  • Figure 7-18: Average Selling Price by Country, Total Demineralized Bone Matrix Market, Europe, 2020 - 2030 (US$)
  • Figure 7-19: Market Value by Country, Total Demineralized Bone Matrix Market, Europe, 2020 - 2030 (€M)
  • Figure 7-20: Market Value by Country, Total Demineralized Bone Matrix Market, Europe, 2020 - 2030 (US$M)
  • Figure 7-21: Synthetic Market, Europe, 2020 - 2030
  • Figure 7-22: Units Sold by Country, Synthetic Market, Europe, 2020 - 2030
  • Figure 7-23: Average Selling Price by Country, Total Synthetic Market, Europe, 2020 - 2030 (€)
  • Figure 7-24: Average Selling Price by Country, Total Synthetic Market, Europe, 2020 - 2030 (US$)
  • Figure 7-25: Market Value by Country, Total Synthetic Market, Europe, 2020 - 2030 (€M)
  • Figure 7-26: Market Value by Country, Total Synthetic Market, Europe, 2020 - 2030 (US$M)
  • Figure 7-27: Total Bone Graft Substitute Units Sold by Indication, Europe, 2020 - 2030 (1 of 2)
  • Figure 7-28: Total Bone Graft Substitute Units Sold by Indication, Europe, 2020 - 2030 (2 of 2)
  • Figure 7-29: Allograft Bone Graft Substitute Units Sold by Indication, Europe, 2020 - 2030
  • Figure 7-30: Spine Allograft Bone Graft Substitute Units Sold by Indication, Europe, 2020 - 2030
  • Figure 7-31: Units Sold by Country, Cervical Spine Allograft Bone Graft Substitute, Europe, 2020 - 2030
  • Figure 7-32: Units Sold by Country, Thoracolumbar Spine Allograft Bone Graft Substitute, Europe, 2020 - 2030
  • Figure 7-33: Trauma Allograft Bone Graft Substitute Units Sold by Indication, Europe, 2020 - 2030
  • Figure 7-34: Units Sold by Country, Non-Union Trauma Allograft Bone Graft Substitute, Europe, 2020 - 2030
  • Figure 7-35: Units Sold by Country, Fresh Fracture Trauma Allograft Bone Graft Substitute, Europe, 2020 - 2030
  • Figure 7-36: Large Joint Reconstruction Allograft Bone Graft Substitute Units Sold by Anatomy, Europe, 2020 - 2030
  • Figure 7-37: Units Sold by Country, Hip Large Joint Reconstruction Allograft Bone Graft Substitute, Europe, 2020 - 2030
  • Figure 7-38: Units Sold by Country, Knee Large Joint Reconstruction Allograft Bone Graft Substitute, Europe, 2020 - 2030
  • Figure 7-39: Units Sold by Country, Foot Reconstruction Allograft Bone Graft Substitute, Europe, 2020 - 2030
  • Figure 7-40: Units Sold by Country, Craniomaxillofacial Allograft Bone Graft Substitute, Europe, 2020 - 2030
  • Figure 7-41: Units Sold by Country, Oncology Allograft Bone Graft Substitute, Europe, 2020 - 2030
  • Figure 7-42: Demineralized Bone Matrix Allograft Units Sold by Indication, Europe, 2020 - 2030
  • Figure 7-43: Spine Demineralized Bone Matrix Allograft Units Sold by Anatomy, Europe, 2020 - 2030
  • Figure 7-44: Units Sold by Country, Cervical Spine Demineralized Bone Matrix Allograft, Europe, 2020 - 2030
  • Figure 7-45: Units Sold by Country, Thoracolumbar Spine Demineralized Bone Matrix Allograft, Europe, 2020 - 2030
  • Figure 7-46: Trauma Demineralized Bone Matrix Allograft Units Sold by Anatomy, Europe, 2020 - 2030
  • Figure 7-47: Units Sold by Country, Non-Union Trauma Demineralized Bone Matrix Allograft, Europe, 2020 - 2030
  • Figure 7-48: Units Sold by Country, Fresh Fracture Trauma Demineralized Bone Matrix Allograft, Europe, 2020 - 2030
  • Figure 7-49: Units Sold by Country, Craniomaxillofacial Demineralized Bone Matrix Allograft, Europe, 2020 - 2030
  • Figure 7-50: Synthetic Bone Graft Substitute Units Sold by Indication, Europe, 2020 - 2030
  • Figure 7-51: Spine Synthetic Bone Graft Substitute Units Sold by Anatomy, Europe, 2020 - 2030
  • Figure 7-52: Units Sold by Country, Cervical Spine Synthetic Bone Graft Substitute, Europe, 2020 - 2030
  • Figure 7-53: Units Sold by Country, Thoracolumbar Spine Synthetic Bone Graft Substitute, Europe, 2020 - 2030
  • Figure 7-54: Trauma Synthetic Bone Graft Substitute Units Sold by Indication, Europe, 2020 - 2030
  • Figure 7-55: Units Sold by Country, Non-Union Trauma Synthetic Bone Graft Substitute, Europe, 2020 - 2030
  • Figure 7-56: Units Sold by Country, Fresh Fracture Trauma Synthetic Bone Graft Substitute, Europe, 2020 - 2030
  • Figure 7-57: Large Joint Reconstruction Synthetic Bone Graft Substitute Units Sold by Anatomy, Europe, 2020 - 2030
  • Figure 7-58: Units Sold by Country, Hip Large Joint Reconstruction Synthetic Bone Graft Substitute, Europe, 2020 - 2030
  • Figure 7-59: Units Sold by Country, Knee Large Joint Reconstruction Synthetic Bone Graft Substitute, Europe, 2020 - 2030
  • Figure 7-60: Units Sold by Country, Foot Reconstruction Synthetic Bone Graft Substitute, Europe, 2020 - 2030
  • Figure 7-61: Units Sold by Country, Craniomaxillofacial Synthetic Bone Graft Substitute, Europe, 2020 - 2030
  • Figure 7-62: Units Sold by Country, Oncology Synthetic Bone Graft Substitute, Europe, 2020 - 2030
  • Figure 7-63: Units Sold by Country, Generation 1 Synthetic Bone Graft Substitute, Europe, 2020 - 2030
  • Figure 7-64: Units Sold by Country, Generation 2 Synthetic Bone Graft Substitute, Europe, 2020 - 2030
  • Figure 7-65: Leading Competitors by Country, Orthopedic Bone Graft Substitute Market, Europe, 2023
  • Figure 7-66: Leading Competitors by Segment, Orthopedic Bone Graft Substitute Market, Europe, 2023
  • Figure 8-1: Orthopedic Growth Factor Market by Segment, Europe, 2020 - 2030 (€M)
  • Figure 8-2: Orthopedic Growth Factor Market by Segment, Europe, 2020 - 2030 (US$M)
  • Figure 8-3: Orthopedic Growth Factor Market, Europe, 2020 - 2030
  • Figure 8-4: Units Sold (5 cc) by Country, Orthopedic Growth Factor Market, Europe, 2020 - 2030
  • Figure 8-5: Average Selling Price by Country, Orthopedic Growth Factor Market, Europe, 2020 - 2030 (€)
  • Figure 8-6: Average Selling Price by Country, Orthopedic Growth Factor Market, Europe, 2020 - 2030 (US$)
  • Figure 8-7: Market Value by Country, Orthopedic Growth Factor Market, Europe, 2020 - 2030 (€M)
  • Figure 8-8: Market Value by Country, Orthopedic Growth Factor Market, Europe, 2020 - 2030 (US$M)
  • Figure 8-9: Spine Orthopedic Growth Factor Market, Europe, 2020 - 2030
  • Figure 8-10: Units Sold (5 cc) by Country, Spine Orthopedic Growth Factor Market, Europe, 2020 - 2030
  • Figure 8-11: Average Selling Price by Country, Spine Orthopedic Growth Factor Market, Europe, 2020 - 2030 (€)
  • Figure 8-12: Average Selling Price by Country, Spine Orthopedic Growth Factor Market, Europe, 2020 - 2030 (US$)
  • Figure 8-13: Market Value by Country, Spine Orthopedic Growth Factor Market, Europe, 2020 - 2030 (€M)
  • Figure 8-14: Market Value by Country, Spine Orthopedic Growth Factor Market, Europe, 2020 - 2030 (US$M)
  • Figure 8-15: Tibial Orthopedic Growth Factor Market, Europe, 2020 - 2030
  • Figure 8-16: Units Sold (5 cc) by Country, Tibial Orthopedic Growth Factor Market, Europe, 2020 - 2030
  • Figure 8-17: Average Selling Price by Country, Tibial Orthopedic Growth Factor Market, Europe, 2020 - 2030 (€)
  • Figure 8-18: Average Selling Price by Country, Tibial Orthopedic Growth Factor Market, Europe, 2020 - 2030 (US$)
  • Figure 8-19: Market Value by Country, Tibial Orthopedic Growth Factor Market, Europe, 2020 - 2030 (€M)
  • Figure 8-20: Market Value by Country, Tibial Orthopedic Growth Factor Market, Europe, 2020 - 2030 (US$M)
  • Figure 8-21: Units Sold (5 cc) by Country, Spine Orthopedic Growth Factor Market, Europe, 2020 - 2030
  • Figure 8-22: Units Sold (5 cc) by Country, Tibial Orthopedic Growth Factor Market, Europe, 2020 - 2030
  • Figure 8-23: Leading Competitors by Country, Orthopedic Growth Factor Market, Europe, 2023
  • Figure 9-1: Orthopedic Cell Therapy Market by Segment, Europe, 2020 - 2030 (€M)
  • Figure 9-2: Orthopedic Cell Therapy Market by Segment, Europe, 2020 - 2030 (US$M)
  • Figure 9-3: Platelet-Rich Plasma Market, Europe, 2020 - 2030
  • Figure 9-4: Units Sold (10 cc) by Country, Platelet-Rich Plasma Market, Europe, 2020 - 2030
  • Figure 9-5: Average Selling Price by Country, Platelet-Rich Plasma Market, Europe, 2020 - 2030 (€)
  • Figure 9-6: Average Selling Price by Country, Platelet-Rich Plasma Market, Europe, 2020 - 2030 (US$)
  • Figure 9-7: Market Value by Country, Platelet-Rich Plasma Market, Europe, 2020 - 2030 (€M)
  • Figure 9-8: Market Value by Country, Platelet-Rich Plasma Market, Europe, 2020 - 2030 (US$M)
  • Figure 9-9: Bone Marrow Aspirate Concentrate Market, Europe, 2020 - 2030
  • Figure 9-10: Units Sold (10 cc) by Country, Bone Marrow Aspirate Concentrate Market, Europe, 2020 - 2030
  • Figure 9-11: Average Selling Price by Country, Bone Marrow Aspirate Concentrate Market, Europe, 2020 - 2030 (€)
  • Figure 9-12: Average Selling Price by Country, Bone Marrow Aspirate Concentrate Market, Europe, 2020 - 2030 (US$)
  • Figure 9-13: Market Value by Country, Bone Marrow Aspirate Concentrate Market, Europe, 2020 - 2030 (€M)
  • Figure 9-14: Market Value by Country, Bone Marrow Aspirate Concentrate Market, Europe, 2020 - 2030 (US$M)
  • Figure 9-15: Units Sold by Country, Soft-Tissue Platelet-Rich Plasma, Europe, 2020 - 2030
  • Figure 9-16: Units Sold by Country, Spine Platelet-Rich Plasma, Europe, 2020 - 2030
  • Figure 9-17: Units Sold by Country, Cardiac Platelet-Rich Plasma, Europe, 2020 - 2030
  • Figure 9-18: Units Sold by Country, Orthopedic Platelet-Rich Plasma, Europe, 2020 - 2030
  • Figure 9-19: Units Sold by Country, Plastics Platelet-Rich Plasma, Europe, 2020 - 2030
  • Figure 9-20: Units Sold (10cc) by Country, Spine Bone Marrow Aspirate Concentrate Market, Europe, 2020 - 2030
  • Figure 9-21: Units Sold (10cc) by Country, Soft-Tissue Bone Marrow Aspirate Concentrate Market, Europe, 2020 - 2030
  • Figure 9-22: Units Sold (10 cc) by Country, Trauma Bone Marrow Aspirate Concentrate Market, Europe, 2020 - 2030
  • Figure 9-23: Units Sold (10 cc) by Country, Joint Reconstruction Bone Marrow Aspirate Concentrate Market, Europe, 2020 - 2030
  • Figure 9-24: Leading Competitors by Country, Orthopedic Cell Therapy Market, Europe, 2023
  • Figure 9-25: Leading Competitors by Segment, Orthopedic Cell Therapy Market, Europe, 2023
  • Figure 9-26: Leading Competitors by Country, Platelet-Rich Cell Therapy Market, Europe, 2023
  • Figure 9-27: Leading Competitors by Country, Bone Marrow Aspirate Concentrate Market, Europe, 2023
  • Figure 10-1: Hyaluronic Acid Viscosupplementation Market by Segment, Europe, 2020 - 2030 (€M)
  • Figure 10-2: Hyaluronic Acid Viscosupplementation Market by Segment, Europe, 2020 - 2030 (US$M)
  • Figure 10-3: Total Hyaluronic Acid Viscosupplementation Market, Europe, 2020 - 2030
  • Figure 10-4: Units Sold (Cycles) by Country, Total Hyaluronic Acid Viscosupplementation Market, Europe, 2020 - 2030
  • Figure 10-5: Average Selling Price by Country, Total Hyaluronic Acid Viscosupplementation Market, Europe, 2020 - 2030 (€)
  • Figure 10-6: Average Selling Price by Country, Total Hyaluronic Acid Viscosupplementation Market, Europe, 2020 - 2030 (US$)
  • Figure 10-7: Market Value by Country, Total Hyaluronic Acid Viscosupplementation Market, Europe, 2020 - 2030 (€M)
  • Figure 10-8: Market Value by Country, Total Hyaluronic Acid Viscosupplementation Market, Europe, 2020 - 2030 (US$M)
  • Figure 10-9: Single-Injection Market, Europe, 2020 - 2030
  • Figure 10-10: Units Sold (Cycles) by Country, Single-Injection Market, Europe, 2020 - 2030
  • Figure 10-11: Average Selling Price by Country, Single-Injection Market, Europe, 2020 - 2030 (€)
  • Figure 10-12: Average Selling Price by Country, Single-Injection Market, Europe, 2020 - 2030 (US$)
  • Figure 10-13: Market Value by Country, Single-Injection Market, Europe, 2020 - 2030 (€M)
  • Figure 10-14: Market Value by Country, Single-Injection Market, Europe, 2020 - 2030 (US$M)
  • Figure 10-15: Two-Injection Market, Europe, 2020 - 2030
  • Figure 10-16: Units Sold (Cycles) by Country, Two-Injection Market, Europe, 2020 - 2030
  • Figure 10-17: Average Selling Price by Country, Two-Injection Market, Europe, 2020 - 2030 (€)
  • Figure 10-18: Average Selling Price by Country, Two-Injection Market, Europe, 2020 - 2030 (US$)
  • Figure 10-19: Market Value by Country, Two-Injection Market, Europe, 2020 - 2030 (€M)
  • Figure 10-20: Market Value by Country, Two-Injection Market, Europe, 2020 - 2030 (US$M)
  • Figure 10-21: Three-Injection Market, Europe, 2020 - 2030
  • Figure 10-22: Units Sold (Cycles) by Country, Three-Injection Market, Europe, 2020 - 2030
  • Figure 10-23: Average Selling Price by Country, Three-Injection Market, Europe, 2020 - 2030 (€)
  • Figure 10-24: Average Selling Price by Country, Three-Injection Market, Europe, 2020 - 2030 (US$)
  • Figure 10-25: Market Value by Country, Three-Injection Market, Europe, 2020 - 2030 (€M)
  • Figure 10-26: Market Value by Country, Three-Injection Market, Europe, 2020 - 2030 (US$M)
  • Figure 10-27: Five-Injection Market, Europe, 2020 - 2030
  • Figure 10-28: Units Sold (Cycles) by Country, Five-Injection Market, Europe, 2020 - 2030
  • Figure 10-29: Average Selling Price by Country, Five-Injection Market, Europe, 2020 - 2030 (€)
  • Figure 10-30: Average Selling Price by Country, Five-Injection Market, Europe, 2020 - 2030 (US$)
  • Figure 10-31: Market Value by Country, Five-Injection Market, Europe, 2020 - 2030 (€M)
  • Figure 10-32: Market Value by Country, Five-Injection Market, Europe, 2020 - 2030 (US$M)
  • Figure 10-33: Leading Competitors by Country, Hyaluronic Acid Viscosupplementation Market, Europe, 2023
  • Figure 11-1: Orthopedic Cartilage Repair Market by Segment, Europe, 2020 - 2030 (€M)
  • Figure 11-2: Orthopedic Cartilage Repair Market by Segment, Europe, 2020 - 2030 (US$M)
  • Figure 11-3: Osteochondral Allograft Market, Europe, 2020 - 2030
  • Figure 11-4: Units Sold by Country, Osteochondral Allograft Market, Europe, 2020 - 2030
  • Figure 11-5: Average Selling Price by Country, Osteochondral Allograft Market, Europe, 2020 - 2030 (€)
  • Figure 11-6: Average Selling Price by Country, Osteochondral Allograft Market, Europe, 2020 - 2030 (US$)
  • Figure 11-7: Market Value by Country, Osteochondral Allograft Market, Europe, 2020 - 2030 (€M)
  • Figure 11-8: Market Value by Country, Osteochondral Allograft Market, Europe, 2020 - 2030 (US$M)
  • Figure 11-9: Meniscal Allograft Market, Europe, 2020 - 2030
  • Figure 11-10: Units Sold by Country, Meniscal Allograft Market, Europe, 2020 - 2030
  • Figure 11-11: Average Selling Price by Country, Meniscal Allograft Market, Europe, 2020 - 2030 (€)
  • Figure 11-12: Average Selling Price by Country, Meniscal Allograft Market, Europe, 2020 - 2030 (US$)
  • Figure 11-13: Market Value by Country, Meniscal Allograft Market, Europe, 2020 - 2030 (€M)
  • Figure 11-14: Market Value by Country, Meniscal Allograft Market, Europe, 2020 - 2030 (US$M)
  • Figure 11-15: Autologous Chondrocyte Implantation Market, Europe, 2020 - 2030
  • Figure 11-16: Units Sold by Country, Autologous Chondrocyte Implantation Market, Europe, 2020 - 2030
  • Figure 11-17: Average Selling Price by Country, Autologous Chondrocyte Implantation Market, Europe, 2020 - 2030 (€)
  • Figure 11-18: Average Selling Price by Country, Autologous Chondrocyte Implantation Market, Europe, 2020 - 2030 (US$)
  • Figure 11-19: Market Value by Country, Autologous Chondrocyte Implantation Market, Europe, 2020 - 2030 (€M)
  • Figure 11-20: Market Value by Country, Autologous Chondrocyte Implantation Market, Europe, 2020 - 2030 (US$M)
  • Figure 11-21: Osteochondral Autograft Market, Europe, 2020 - 2030
  • Figure 11-22: Units Sold by Country, Osteochondral Autograft Market, Europe, 2020 - 2030
  • Figure 11-23: Average Selling Price by Country, Osteochondral Autograft Market, Europe, 2020 - 2030 (€)
  • Figure 11-24: Average Selling Price by Country, Osteochondral Autograft Market, Europe, 2020 - 2030 (US$)
  • Figure 11-25: Market Value by Country, Osteochondral Autograft Market, Europe, 2020 - 2030 (€M)
  • Figure 11-26: Market Value by Country, Osteochondral Autograft Market, Europe, 2020 - 2030 (US$M)
  • Figure 11-27: Leading Competitors, Orthopedic Cartilage Repair Market, Europe, 2023